Rituximab use in adult glomerulopathies and its rationale
J. bras. nefrol; 42 (1), 2020
Abstract Glomerulopathies are one of the leading causes of end-stage renal disease. In the last years, clinical research has made significant contributions to the understanding of such conditions. Recently, rituximab (RTX) has appeared as a reasonably safe treatment. The Kidney Disease: Improving Global ...
Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/tratamiento farmacológico, Glomerulonefritis/tratamiento farmacológico, Inmunosupresores/efectos adversos, Nefrosis Lipoidea/tratamiento farmacológico, Ensayos Clínicos Controlados Aleatorios como Asunto, Rituximab/efectos adversos, Resultado del Tratamiento